Literature DB >> 25115300

BRG1/SMARCA4 inactivation promotes non-small cell lung cancer aggressiveness by altering chromatin organization.

Tess Orvis1, Austin Hepperla1,2, Vonn Walter1, Ian J Davis1,3,4, Bernard Weissman1,5, Shujie Song1,6, Jeremy Simon1,7, Joel Parker1,3, Matthew D Wilkerson1,3, Nisarg Desai1, Michael B Major1,8, D Neil Hayes1,9.   

Abstract

SWI/SNF chromatin remodeling complexes regulate critical cellular processes, including cell-cycle control, programmed cell death, differentiation, genomic instability, and DNA repair. Inactivation of this class of chromatin remodeling complex has been associated with a variety of malignancies, including lung, ovarian, renal, liver, and pediatric cancers. In particular, approximately 10% of primary human lung non-small cell lung cancers (NSCLC) display attenuations in the BRG1 ATPase, a core factor in SWI/SNF complexes. To evaluate the role of BRG1 attenuation in NSCLC development, we examined the effect of BRG1 silencing in primary and established human NSCLC cells. BRG1 loss altered cellular morphology and increased tumorigenic potential. Gene expression analyses showed reduced expression of genes known to be associated with progression of human NSCLC. We demonstrated that BRG1 losses in NSCLC cells were associated with variations in chromatin structure, including differences in nucleosome positioning and occupancy surrounding transcriptional start sites of disease-relevant genes. Our results offer direct evidence that BRG1 attenuation contributes to NSCLC aggressiveness by altering nucleosome positioning at a wide range of genes, including key cancer-associated genes. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25115300      PMCID: PMC4233181          DOI: 10.1158/0008-5472.CAN-14-0061

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  60 in total

Review 1.  ATP-dependent chromatin remodelling: SWI/SNF and Co. are on the job.

Authors:  C Muchardt; M Yaniv
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

2.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

Review 3.  ATP-dependent remodeling and acetylation as regulators of chromatin fluidity.

Authors:  R E Kingston; G J Narlikar
Journal:  Genes Dev       Date:  1999-09-15       Impact factor: 11.361

4.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

5.  The human genome browser at UCSC.

Authors:  W James Kent; Charles W Sugnet; Terrence S Furey; Krishna M Roskin; Tom H Pringle; Alan M Zahler; David Haussler
Journal:  Genome Res       Date:  2002-06       Impact factor: 9.043

6.  Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

Authors:  K Xu; H Ma; T J McCown; I M Verma; T Kafri
Journal:  Mol Ther       Date:  2001-01       Impact factor: 11.454

7.  Human Semaphorin 3B (SEMA3B) located at chromosome 3p21.3 suppresses tumor formation in an adenocarcinoma cell line.

Authors:  Christin Tse; Ruinua H Xiang; Todd Bracht; Susan L Naylor
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

8.  Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B.

Authors:  Y Tomizawa; Y Sekido; M Kondo; B Gao; J Yokota; J Roche; H Drabkin; M I Lerman; A F Gazdar; J D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-20       Impact factor: 11.205

9.  The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression.

Authors:  M W Strobeck; M F DeCristofaro; F Banine; B E Weissman; L S Sherman; E S Knudsen
Journal:  J Biol Chem       Date:  2000-12-06       Impact factor: 5.157

10.  Semaphorins as mediators of neuronal apoptosis.

Authors:  A Shirvan; I Ziv; G Fleminger; R Shina; Z He; I Brudo; E Melamed; A Barzilai
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

View more
  50 in total

1.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

2.  Modeling gene-wise dependencies improves the identification of drug response biomarkers in cancer studies.

Authors:  Olga Nikolova; Russell Moser; Christopher Kemp; Mehmet Gönen; Adam A Margolin
Journal:  Bioinformatics       Date:  2017-05-01       Impact factor: 6.937

3.  Integration of protein phosphorylation, acetylation, and methylation data sets to outline lung cancer signaling networks.

Authors:  Mark Grimes; Benjamin Hall; Lauren Foltz; Tyler Levy; Klarisa Rikova; Jeremiah Gaiser; William Cook; Ekaterina Smirnova; Travis Wheeler; Neil R Clark; Alexander Lachmann; Bin Zhang; Peter Hornbeck; Avi Ma'ayan; Michael Comb
Journal:  Sci Signal       Date:  2018-05-22       Impact factor: 8.192

Review 4.  Update on genetically defined lung neoplasms: NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.

Authors:  Kyriakos Chatzopoulos; Jennifer M Boland
Journal:  Virchows Arch       Date:  2021-01-06       Impact factor: 4.064

5.  H4K5 histone acetylation of BRG1 is associated with heroin administration rather than addiction.

Authors:  Limin Xu; Qingxiao Hong; Xiaoying Chen; Xuting Xu; Huifen Liu; Wenhua Zhou; Shiwei Duan
Journal:  Exp Ther Med       Date:  2016-07-13       Impact factor: 2.447

6.  Ponatinib Shows Potent Antitumor Activity in Small Cell Carcinoma of the Ovary Hypercalcemic Type (SCCOHT) through Multikinase Inhibition.

Authors:  Jessica D Lang; William P D Hendricks; Krystal A Orlando; Hongwei Yin; Jeffrey Kiefer; Pilar Ramos; Ritin Sharma; Patrick Pirrotte; Elizabeth A Raupach; Chris Sereduk; Nanyun Tang; Winnie S Liang; Megan Washington; Salvatore J Facista; Victoria L Zismann; Emily M Cousins; Michael B Major; Yemin Wang; Anthony N Karnezis; Aleksandar Sekulic; Ralf Hass; Barbara C Vanderhyden; Praveen Nair; Bernard E Weissman; David G Huntsman; Jeffrey M Trent
Journal:  Clin Cancer Res       Date:  2018-02-09       Impact factor: 12.531

7.  The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer.

Authors:  Chai Bandlamudi; Jessica A Lavery; Joseph Montecalvo; Azadeh Namakydoust; Natasha Rekhtman; Gregory J Riely; Adam J Schoenfeld; Hira Rizvi; Jacklynn Egger; Carla P Concepcion; Sonal Paul; Maria E Arcila; Yahya Daneshbod; Jason Chang; Jennifer L Sauter; Amanda Beras; Marc Ladanyi; Tyler Jacks; Charles M Rudin; Barry S Taylor; Mark T A Donoghue; Glenn Heller; Matthew D Hellmann
Journal:  Clin Cancer Res       Date:  2020-07-24       Impact factor: 12.531

8.  The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies.

Authors:  Thomas A Paul; Parantu K Shah; Bhavatarini Vangamudi; Maria Kost-Alimova; Lisa Nottebaum; Xi Shi; Yanai Zhan; Elisabetta Leo; Harshad S Mahadeshwar; Alexei Protopopov; Andrew Futreal; Trang N Tieu; Mike Peoples; Timothy P Heffernan; Joseph R Marszalek; Carlo Toniatti; Alessia Petrocchi; Dominique Verhelle; Dafydd R Owen; Giulio Draetta; Philip Jones; Wylie S Palmer; Shikhar Sharma; Jannik N Andersen
Journal:  Cancer Res       Date:  2015-07-02       Impact factor: 12.701

9.  Loss of switch/sucrose non-fermenting complex protein expression is associated with dedifferentiation in endometrial carcinomas.

Authors:  Anthony N Karnezis; Lien N Hoang; Mackenzie Coatham; Sarah Ravn; Noorah Almadani; Basile Tessier-Cloutier; Julie Irving; Bo Meng; Xiaodong Li; Christine Chow; Jessica McAlpine; Kuan-Ting Kuo; Tsui-Lien Mao; Bojana Djordjevic; Robert A Soslow; David G Huntsman; C Blake Gilks; Martin Köbel; Cheng-Han Lee
Journal:  Mod Pathol       Date:  2016-01-08       Impact factor: 7.842

10.  Brg1 Enables Rapid Growth of the Early Embryo by Suppressing Genes That Regulate Apoptosis and Cell Growth Arrest.

Authors:  Ajeet P Singh; Julie F Foley; Mark Rubino; Michael C Boyle; Arpit Tandon; Ruchir Shah; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2016-07-14       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.